Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|July 1, 1986
Defect symptoms and abnormal involuntary movement in schizophreniaA C Iager, D G Kirch, D V Jeste, et al.
Schizophrenia Research|January 1, 1988
Schizophrenia, just the facts. What do we know, how well do we know it?R J Wyatt, R C Alexander, M F Egan, et al.
Schizophrenia Research|September 1, 1994
Effects of water loading in schizophrenic patients with polydipsia-hyponatremia: an MRI pilot studyA M Elkashef, F Issa, A Gindraw, et al.
Psychiatry Research|September 1, 1988
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatientsD G Kirch, G Jaskiw, M Linnoila, et al.
Schizophrenia Research|February 1, 1994
Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medicationD Glovinsky, K T Kalogeras, D G Kirch, et al.
Psychopharmacology|January 1, 1992
Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slicesR Li, L L Wing, D G Kirch, et al.
Schizophrenia Research|October 1, 1991
The continued search for evidence of retroviral infection in schizophrenic patientsM A Coggiano, R C Alexander, D G Kirch, et al.
Biological Psychiatry|October 1, 1985
Abnormal cerebrospinal fluid protein indices in schizophreniaD G Kirch, C A Kaufmann, N M Papadopoulos, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1992
Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptorsD G Kirch, T R Taylor, I Creese, et al.
Clinical Neuropharmacology|August 1, 1987
Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brainD G Kirch, G A Gerhardt, R C Shelton, et al.
Pageof 6